Trial intelligence / Profile preview

Magnesium sulphate versus dexmedetomidine for cough suppression during anesthetic emergence in smokers

PACTR202308591985746Phase 4Recruiting

Sponsor
Ain Shams University Faculty of Medicine
Start
Jul 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of magnesium sulfate, dexmedetomidine and Normal Saline-Benha University in cough (3 arms), sponsored by Ain Shams University Faculty of Medicine. Primary endpoint: Severity and incidence of cough. Started Jul 2022; status: recruiting.

02

Drugs

magnesium sulfatedexmedetomidineNormal Saline-Benha University
03

Conditions

cough

Beyond the preview

Go deeper on PACTR202308591985746.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202308591985746.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call